MORF4L1P6

Across TCGA pan-cancer cohorts, MORF4L1P6 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MORF4L1P6 data layer.

The strongest signal is observed in sarcoma (SARC), where higher MORF4L1P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MORF4L1P6 expression acts as an unfavorable survival marker.

SARC, ESCA, and OV are the cancer types where MORF4L1P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	OS	Tertile	All	0.221	0.841	<.001	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
OV	DFS	Tertile	II,III,IV	0.320	0.542	.046	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	27	view →
BLCA	DFS	Tertile	All	0.174	0.625	.023	18	view →
SKCM	DFS	Tertile	All	0.023	0.738	<.001	18	view →
LIHC	OS	Tertile	All	0.118	0.707	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MORF4L1P6–SARC (OS)

Open the SARC breakdown →